Nasdaq: ALLO
Allogene Therapeutics insiders
The officers, directors and 10% owners of Allogene Therapeutics, Inc. who hold the most stock, valued at the live ALLO price.
$0.67
ALLO today −$29K (−4.17%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their ALLO stock
- $9.9M
- Market value
- $249M
- Held by ranked insiders
- 3.97%
Insiders by value of ALLO holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Arie Belldegrun | Director | 7,486,803 | $5.0M | 2.00% | 5599th |
| 2 | David D. Chang | President and CEO | 7,207,751 | $4.8M | 1.93% | 14617th |
| 3 | Vicki L. Sato | Director | 162,575 | $108K | <0.1% | 7844th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Allogene Therapeutics; see each profile for the filing.